Next Article in Journal
Social Stress-Induced Oxidative DNA Damage Is Related to Prospective Cardiovascular Risk
Next Article in Special Issue
Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease
Previous Article in Journal
The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease
Review

Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes

Department of Medicine, Division of Hematology/Oncology, Center of Excellence for Sickle Cell Disease, Center for Regenerative Medicine, Genome Science Institute, Boston University School of Medicine and Boston Medical Center, 72 E. Concord St., Boston, MA 02118, USA
J. Clin. Med. 2020, 9(11), 3782; https://doi.org/10.3390/jcm9113782
Received: 3 November 2020 / Revised: 17 November 2020 / Accepted: 19 November 2020 / Published: 23 November 2020
Fetal hemoglobin (HbF) usually consists of 4 to 10% of total hemoglobin in adults of African descent with sickle cell anemia. Rarely, their HbF levels reach more than 30%. High HbF levels are sometimes a result of β-globin gene deletions or point mutations in the promoters of the HbF genes. Collectively, the phenotype caused by these mutations is called hereditary persistence of fetal hemoglobin, or HPFH. The pancellularity of HbF associated with these mutations inhibits sickle hemoglobin polymerization in most sickle erythrocytes so that these patients usually have inconsequential hemolysis and few, if any, vasoocclusive complications. Unusually high HbF can also be associated with variants of the major repressors of the HbF genes, BCL11A and MYB. Perhaps most often, we lack an explanation for very high HbF levels in sickle cell anemia. View Full-Text
Keywords: hereditary persistence of fetal hemoglobin; gamma-globin gene; gene deletion; globin gene expression; genotype/phenotype hereditary persistence of fetal hemoglobin; gamma-globin gene; gene deletion; globin gene expression; genotype/phenotype
Show Figures

Figure 1

MDPI and ACS Style

Steinberg, M.H. Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes. J. Clin. Med. 2020, 9, 3782. https://doi.org/10.3390/jcm9113782

AMA Style

Steinberg MH. Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes. Journal of Clinical Medicine. 2020; 9(11):3782. https://doi.org/10.3390/jcm9113782

Chicago/Turabian Style

Steinberg, Martin H. 2020. "Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes" Journal of Clinical Medicine 9, no. 11: 3782. https://doi.org/10.3390/jcm9113782

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop